Medicilon also offers other services including but not limited to evaluation of compound medicines, chemical drugs, biological drug development and IND filing。
Medicilon is a Preclinical Research Outsourcing (CRO) company。 With our more than 10 years experience on preclinical research services, we dedicated to provide our clients with customized preclinical services program in drug metabolism, pharmacokinetics, efficacy studies, and toxicology。
We utilize medicinal chemistry and computational chemistry to design and synthesize drug-like templates and libraries of compounds to increase our clients' compound collections. The annual capacity of library production is more than 100,000 compounds.
Medicilon’s Chemistry department provides custom synthesis, medicinal chemistry, focus library preparation, chemical drug development and process and scale-up synthesis。
Medicilon has extensive research experience in bio drug development. From initial construction of cDNA library to drug design, as well as from protein purification to structural determination and assays, we provide a complete set of biological services.